Laurus Labs Limited
LAURUSLABS
Clasificación en acciones
#1745
Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited,... Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited, along with its subsidiaries, operates as a diversified global pharmaceutical company. It focuses on the research, manufacturing, and international distribution of a broad spectrum of medicines and active pharmaceutical ingredients (APIs). The company's API and advanced intermediate offerings cover key therapeutic domains such as anti-retroviral (ARV), antidiabetic, cardiovascular, proton pump inhibitors (PPIs), oncology, gastroenterology, and hepatitis C. Additionally, Laurus Labs develops and produces oral solid dosage forms targeting ARV, antidiabetic, cardiovascular, PPI, and central nervous system (CNS) conditions. Beyond its proprietary products, the firm extends its expertise through contract development and manufacturing services for other pharmaceutical enterprises. It also supplies specialized ingredients vital for nutraceutical, dietary supplement, and cosmeceutical applications. Furthermore, Laurus Labs is at the forefront of innovation, engineering novel enzymatic solutions for industrial biotechnology, and providing animal-origin-free recombinant proteins and enzymes for biopharmaceutical use, alongside offering a range of business support services within the pharmaceutical industry.
Precio por acción
$22.83
Última sincronización: 2026-10-19
Capitalización bursátil
$12.34B
Cambio (1 día)
0.51%
Cambio (1 año)
117.95%
País
IN
Comercio Laurus Labs Limited (LAURUSLABS)
Categoría
Healthcare
Número de acciones en circulación de Laurus Labs Limited (LAURUSLABS)
Número de acciones en circulación al June 2026: 539.79M
Según los últimos informes financieros y el precio de las acciones de Laurus Labs Limited, el número actual de acciones en circulación es 539.79M. Al final de March 2024, la empresa tenía 540.57M acciones en circulación. El número de acciones en circulación generalmente se ve afectado por divisiones de acciones y recompras.
Historial de acciones en circulación de Laurus Labs Limited (LAURUSLABS) desde 2013 hasta 2026
Acciones en circulación al final de cada año
| Año | Acciones en circulación | Cambiar |
|---|---|---|
| 2026 (TTM) | 539.79M | 0.03% |
| 2025 | 539.64M | -0.17% |
| 2024 | 540.57M | 0.16% |
| 2023 | 539.69M | 0.11% |
| 2022 | 539.10M | 0.19% |
| 2021 | 538.06M | 0.87% |
| 2020 | 533.42M | 0.13% |
| 2019 | 532.75M | 0.19% |
| 2018 | 531.76M | 16.15% |
| 2017 | 457.83M | -6.95% |
| 2016 | 492.04M | 10.95% |
| 2015 | 443.48M | 0.00% |
| 2014 | 443.48M | 9.11% |
| 2013 | 406.44M | 0.00% |
Acciones en circulación de empresas similares o competidores
| Empresa | Acciones en circulación | Diferencia | País |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | 344.49% |
IN
|
